The National Cancer Institute is offering a grant to support the advanced development of emerging molecular or cellular analysis technologies for basic and clinical cancer research. This grant seeks R33 applications with proof-of-principle and preliminary data showcasing innovative capabilities in targeting, probing, or assessing cancer biology. Projects must have the potential to enhance research in cancer biology, early detection, clinical diagnosis, treatment, epidemiology, and cancer health disparities. Technologies should aim to improve molecular and cellular characterizations of cancer, excluding projects based on established technologies with no novel biological or clinical focus. Closing date for applications is September 26, 2016.
Opportunity ID: 280443
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-16-002 |
| Funding Opportunity Title: | Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 10 |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 09, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 26, 2016 |
| Current Closing Date for Applications: | Sep 26, 2016 |
| Archive Date: | Oct 27, 2016 |
| Estimated Total Program Funding: | $4,000,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Private institutions of higher education Public and State controlled institutions of higher education For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the advanced development of emerging molecular or cellular analysis technologies for basic or clinical cancer research. This FOA solicits R33 applications where proof-of-principle for the emerging technology or methodology has been provided with supportive preliminary data demonstrating a novel capability for targeting, probing, or assessing molecular and cellular features of cancer biology. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or cancer health disparities. Technologies proposed for development may be intended to have widespread applicability but must be focused on improving molecular and/or cellular characterizations of cancer. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this solicitation and will not be reviewed. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-16-002.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-C | FORMS-C | PKG00220033 | Jan 26, 2016 | Mar 23, 2016 | View | |
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00221842 | Apr 26, 2016 | Sep 26, 2016 | View |
Package 1
Mandatory forms
280443 RR_SF424_2_0-2.0.pdf
280443 PHS398_ResearchPlan_2_0-2.0.pdf
280443 PHS398_CoverPageSupplement_2_0-2.0.pdf
280443 RR_Budget_1_3-1.3.pdf
280443 RR_KeyPersonExpanded_2_0-2.0.pdf
280443 RR_OtherProjectInfo_1_3-1.3.pdf
280443 PerformanceSite_2_0-2.0.pdf
Optional forms
280443 PlannedReport-1.0.pdf
280443 PHS398_CumulativeInclusionReport-1.0.pdf
280443 RR_SubawardBudget30_1_3-1.3.pdf
Package 2
Mandatory forms
280443 RR_SF424_2_0-2.0.pdf
280443 PHS398_CoverPageSupplement_3_0-3.0.pdf
280443 RR_OtherProjectInfo_1_3-1.3.pdf
280443 PerformanceSite_2_0-2.0.pdf
280443 RR_KeyPersonExpanded_2_0-2.0.pdf
280443 RR_Budget_1_3-1.3.pdf
280443 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
280443 RR_SubawardBudget30_1_3-1.3.pdf
280443 PHS_Inclusion_Enrollment_Report-1.0.pdf
280443 PHS_AssignmentRequestForm-1.0.pdf